Tag Archives: joint hypermobility

Research: ME/CFS is not influenced by the presence or absence of joint hypermobility

Posted on 09/30/2021 by wames

The presentation of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is not influenced by the presence or absence of joint hypermobility, by Sarah K Vogel, Isabelle R Primavera, Colleen L Marden, Marissa AK Flaherty, Richard L Violand, Peter C Rowe in the Journal of … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Research: ME/CFS is not influenced by the presence or absence of joint hypermobility

Beyond bones: the relevance of variants of connective tissue (hypermobility) to FM, ME/CFS & controversies surrounding diagnostic classification

Posted on 01/29/2021 by wames

Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study, by Jessica A Eccles, Beth Thompson, Kristy Themelis, Marisa L Amato, Robyn Stocks, Amy Pound, Anna-Marie Jones, Zdenka Cipinova, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , | Comments Off on Beyond bones: the relevance of variants of connective tissue (hypermobility) to FM, ME/CFS & controversies surrounding diagnostic classification

Impact of ME on treatment of comorbidities: a lived experience

Posted on 08/03/2020 by wames

Impact of myalgic encephalomyelitis on treatment of  comorbidities: a lived experience, by Denise Lopez-Majano in Work vol. 66, no. 2, pp. 309-313, 20 Jul 2020 [DOI: 10.3233/WOR-203175]   Abstract: Myalgic Encephalomyelitis (ME) is a complex, chronic, disabling, multi-system disease with no … Continue reading →

Posted in News | Tagged , , , , | Comments Off on Impact of ME on treatment of comorbidities: a lived experience